midazolam and fosaprepitant

midazolam has been researched along with fosaprepitant in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Caro, L; Jin, B; Marbury, TC; Murphy, G; Ngo, PL; Panebianco, D; Shadle, CR; Valentine, J	1

Reviews

1 review(s) available for midazolam and fosaprepitant

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for midazolam and fosaprepitant

Article	Year
Pharmacokinetics of oral dexamethasone and midazolam when administered with single-dose intravenous 150 mg fosaprepitant in healthy adult subjects. Journal of clinical pharmacology, 2011, Volume: 51, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Aprepitant; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Female; Humans; Injections, Intravenous; Male; Midazolam; Morpholines; Neurokinin-1 Receptor Antagonists; Young Adult	2011

Article

Year

Pharmacokinetics of oral dexamethasone and midazolam when administered with single-dose intravenous 150 mg fosaprepitant in healthy adult subjects.

Journal of clinical pharmacology, 2011, Volume: 51, Issue:12

Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Aprepitant; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Female; Humans; Injections, Intravenous; Male; Midazolam; Morpholines; Neurokinin-1 Receptor Antagonists; Young Adult

2011